Evidence map›Paper›PMID 27057273›Full record

ReviewOxidative medicine and cellular longevity2016

Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents.

Pasupuleti Visweswara Rao, Devi Nallappan, Kondeti Madhavi, Shafiqur Rahman, Lim Jun Wei, Siew Hua Gan

Abstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Synthesis of Graphene@CPharmaceutical nanotechnology · 2025
    Article
  9. Article
  10. Review
  11. Biogenic metallic nanoparticles: from green synthesis to clinical translation.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  12. Advances in nano-immunotherapy for hematological malignancies.Experimental hematology & oncology · 2024
    Review
  13. Evaluation of oyster mushroom (International journal of medical sciences · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pasupuleti Visweswara RaoBiotechnology Program, Faculty of Agro-Based Industry, Universiti Malaysia Kelantan, Campus Jeli, 17600 Jeli, Malaysia.
Devi NallappanBiotechnology Program, Faculty of Agro-Based Industry, Universiti Malaysia Kelantan, Campus Jeli, 17600 Jeli, Malaysia.
Kondeti MadhaviDepartment of Biochemistry, Sri Venkateswara Medical College, Tirupati, Andhra Pradesh 517502, India.
Shafiqur RahmanDepartment of Parasitology, Graduate School of Health Sciences, Kobe University, Kobe 654-0142, Japan.
Lim Jun WeiDepartment of Fundamental and Applied Sciences, Universiti Teknologi Petronas, 32610 Tronoh, Malaysia.
Siew Hua GanHuman Genome Centre, Universiti Sains Malaysia, 16150 Kubang Kerian, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a leading cause of death worldwide. Several classes of drugs are available to treat different types of cancer. Currently, researchers are paying significant attention to the development of drugs at the nanoscale level to increase their target specificity and to reduce their concentrations. Nanotechnology is a promising and growing field with multiple subdisciplines, such as nanostructures, nanomaterials, and nanoparticles. These materials have gained prominence in science due to their size, shape, and potential efficacy. Nanomedicine is an important field involving the use of various types of nanoparticles to treat cancer and cancerous cells. Synthesis of nanoparticles targeting biological pathways has become tremendously prominent due to the higher efficacy and fewer side effects of nanodrugs compared to other commercial cancer drugs. In this review, different medicinal plants and their active compounds, as well as green-synthesized metallic nanoparticles from medicinal plants, are discussed in relation to their anticancer activities.

Indexed as

Antineoplastic AgentsGreen Chemistry TechnologyHumansMetal NanoparticlesNanomedicineNeoplasmsPhytochemicalsAntineoplastic AgentsPhytochemicals

Identifiers

PMID27057273
PMCPMC4781993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.